A 72-year-old woman with a history of hypertension on hydrochlorothiazide and lisinopril presents with a 2-week history of nausea, fatigue, and mild headache. On examination, she is alert but appears mildly confused; blood pressure is 135/80 mmHg, heart rate 92/min, and there is no clinical evidence of edema or ascites. Skin turgor is normal. Laboratory findings: Na⁺ 124 mEq/L, K⁺ 5.2 mEq/L, Cl⁻ 98 mEq/L, HCO₃⁻ 22 mEq/L, creatinine 1.1 mg/dL (baseline 0.9), urine osmolality 420 mOsm/kg, serum osmolality 260 mOsm/kg, urine Na⁺ 28 mEq/L. What is the most likely diagnosis?

Explanation

## Diagnosis: Thiazide-Induced Hypovolemic Hyponatremia ### Clinical Recognition **Key Point:** This is a classic presentation of **thiazide diuretic-induced hypovolemic hyponatremia**. Hydrochlorothiazide (HCTZ) is the most common drug cause of hyponatremia in the elderly, and it acts primarily by causing **sodium and water loss** (hypovolemic mechanism), not by a true SIADH-like euvolemic mechanism. Key findings in this patient: - Chronic thiazide use (hydrochlorothiazide) - **Mild hyperkalemia** (K⁺ 5.2) and **mild creatinine elevation** (1.1 vs baseline 0.9) — subtle signs of volume depletion - Urine osmolality 420 mOsm/kg — concentrated urine indicating ADH activity secondary to volume depletion - **Urine Na⁺ 28 mEq/L** — this is the critical discriminator ### Why Urine Na⁺ 28 mEq/L Points to Hypovolemia, NOT SIADH | Feature | Hypovolemic Hyponatremia (Thiazide) | Euvolemic (True SIADH) | Hypervolemic | |---------|--------------------------------------|------------------------|--------------| | **Clinical signs** | Subtle: normal or near-normal turgor, mild ↑Cr | Normal BP, no edema, no ↑Cr | Edema, ascites, JVD | | **Urine Na⁺** | 20–40 mEq/L (diuretic still active) | **>40 mEq/L** (hallmark) | <10 mEq/L | | **Urine osmolality** | High (>400) | High (>200) | Variable | | **Serum K⁺** | Often low (diuretic) or mildly elevated (volume depletion) | Normal | Variable | | **Creatinine** | Mildly elevated (pre-renal) | Normal | Elevated | **High-Yield:** In true SIADH, urine Na⁺ is typically **>40 mEq/L** because the kidneys are functioning normally and excreting the sodium load. A urine Na⁺ of 28 mEq/L is **below the SIADH threshold** and is more consistent with mild hypovolemia where sodium reabsorption is partially activated — but the diuretic effect of HCTZ prevents the urine Na⁺ from falling below 10 mEq/L (as would be seen in pure GI loss). ### Mechanism of Thiazide-Induced Hypovolemic Hyponatremia Thiazides inhibit the **Na⁺-Cl⁻ cotransporter in the distal convoluted tubule**, causing: 1. **Urinary Na⁺ and Cl⁻ loss** → volume depletion → secondary ADH release 2. **Impaired diluting segment** → inability to excrete free water → water retention 3. Net result: **hypovolemic hyponatremia** with concentrated urine This is distinct from SIADH, where ADH is elevated without a volume stimulus. ### Why NOT the Other Options? - **Option B (GI fluid loss):** No history of vomiting or diarrhea; urine Na⁺ would be <10 mEq/L in pure GI loss (avid renal Na⁺ retention without diuretic interference) - **Option C (Euvolemic SIADH from thiazide):** Urine Na⁺ of 28 mEq/L is below the SIADH threshold of >40 mEq/L; mild ↑Cr and ↑K⁺ suggest volume depletion, not euvolemia - **Option D (Hypervolemic/AKI):** No edema, no ascites, creatinine only mildly elevated from baseline — does not support hypervolemic state **Clinical Pearl:** Thiazide-induced hyponatremia is **hypovolemic** in mechanism, even when clinical signs of volume depletion are subtle. The diuretic effect keeps urine Na⁺ in the 20–40 range (not <10), which can mislead toward a SIADH diagnosis. The mild creatinine rise and hyperkalemia are the key clues to underlying volume depletion. *(Harrison's Principles of Internal Medicine, 21st ed., Chapter on Fluid and Electrolyte Disorders)* ### Management 1. **Stop hydrochlorothiazide** — definitive treatment 2. **Isotonic saline (0.9% NaCl)** to correct volume depletion — this will suppress ADH and allow free water excretion 3. **Monitor Na⁺** every 4–6 hours; correct at ≤8–10 mEq/L per 24 hours to avoid osmotic demyelination 4. Consider alternative antihypertensive (ACE inhibitor alone, or calcium channel blocker) 5. Avoid fluid restriction (appropriate for SIADH, but harmful in hypovolemic hyponatremia)